The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
How Inversion Deals Help Drug Makers Save on Taxes
Posted
July 15, 2014
Views
6,936
Likes
62
Comments
24
Engagement
July 15, 2014
6,936
62
24
1.24%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:41Now PlayingDrug companies and medical device makers are making multi-billion-dollar merger deals to avoid high U.S. corporate taxes. How do so-called "inversion deals" work? WSJ's Jason Bellini has The Short Answer.
Subscribe to the WSJ channel here:
Visit the WSJ channel for more video:
More from the Wall Street Journal:
Visit WSJ.com
Follow WSJ on Facebook:
Follow WSJ on Google+
Follow WSJ on Twitter
Follow WSJ on Instagram
Follow WSJ on Pinterest
Follow WSJ on Tumblr
Don’t miss a WSJ video, subscribe here
More from the Wall Street Journal:
Visit WSJ.com
Visit the WSJ Video Center
On Facebook
On Snapchat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
